Advantages of coagulation self-management Patients who self-monitor often comment on how much more in control they feel of their body and their life. Self-management allows for: Security Independence Quality of life e number of patients taking oral anticoagulants 1 (e.g. Warfarin®) is growing constantly. ey must have their coagulation status tested regularly. is is normally done by their physician, but more and more patients become self-managers and monitor their coagulation independently. Anticoagulation and Self-Management More than patients worldwide are on permanent anticoagulation therapy. 2 10 million Anticoagulants such as vitamin K antagonists (e.g. Warfarin ® ) reduce the formation of dan- gerous blood clots. Anticoagulants 3 Common medical conditions which require anticoagulation therapy Coagulation control Regular coagulation monitoring is important to balance the risk between clotting and bleeding. By the patient himself By the physician Beware: The risk of bleeding is increased if the dose of anticoagulants is too high. Good to know The INR value is the most common way to measure blood coagu- lation. Each patient taking vitamin K an- tagonists gets an INR target range from his physician to minimize the risk of complication. 0 1 2 3 4 5 6 7 8 Risk area for a blood clot Risk area of bleeding INR target range How to become a self-manager Green light from the physician Specialized training 1 All information applies to patients taking vitamin K antagonists. 2 Source: www.ismaap.org 3 Source: www.bhf.org.uk Atrial fibrillation rombosis, embolisms Artificial heart valve COAGUCHEK and BECAUSE IT’S MY LIFE are trademarks of Roche. ©2012 Roche Roche Diagnostics International Ltd, CH-6343 Rotkreuz, Switzerland. www.coaguchek.com
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Advantages of coagulation self-managementPatients who self-monitor often comment on how much more in control they feel of their body and their life. Self-management allows for:
Security Independence Qualityof life
�e number of patients taking oral anticoagulants1 (e.g. Warfarin®) is growing constantly. �ey must have their coagulation status tested regularly. �is is normally done by their physician, but more and more patients become self-managers and monitor their coagulation independently.
Anticoagulation and Self-Management
More than
patients worldwide are on permanent
anticoagulation therapy.2
10 million
Anticoagulants such as vitamin K antagonists (e.g. Warfarin®) reduce the formation of dan- gerous blood clots.
Anticoagulants3
Common medicalconditions which requireanticoagulation therapy
CoagulationcontrolRegular coagulation monitoringis important to balance the riskbetween clotting and bleeding.
By the patient himself
By the physician Beware:The risk of bleeding is increasedif the dose of anticoagulants is too high.
Good to knowThe INR value is the most common way to measure blood coagu-lation. Each patient taking vitamin K an-tagonists gets an INR target range from his physician to minimize the risk of complication. 0
12345678
Risk area for a blood clot
Risk area of bleeding
INR target range
How to becomea self-managerGreen light fromthe physician
Specializedtraining
1 All information applies to patients taking vitamin K antagonists.2 Source: www.ismaap.org3 Source: www.bhf.org.uk
Atrial�brillation
�rombosis,embolisms
Arti�cialheart valve
COAGUCHEK and BECAUSE IT’S MY LIFE are trademarks of Roche. ©2012 RocheRoche Diagnostics International Ltd, CH-6343 Rotkreuz, Switzerland. www.coaguchek.com
Related Documents
